Twist Bioscience News and Activities
Presence
Twist Bioscience makes synthetic DNA and related biotechnology products. Its main offerings include gene synthesis, DNA libraries, and antibody discovery services for researchers, drug developers, and industrial customers.
Twist Bioscience products and services overview:
- Gene synthesis
- DNA libraries
- Antibody discovery
- NGS tools
- DNA storage
- Research services
Revenue: ~$313 million
Employees: 950
Headquarters: South San Francisco, United States (USA)
Twist Bioscience is one of the...
Twist Bioscience is a company listed under the stock ticker TWST (US).
Executives
View the org chart displaying its 24 main executives
Most searched biographies at Twist Bioscience
- Emily Leproust, Chief Executive Officer and Director
- Bob Ragusa, Director
- Rob Chess, Chairman of the Board
Create your alert
to follow the executive moves at Twist Bioscience.
Biotechnology
Twist Bioscience has 2,425 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).
Popular M&A news in Biotechnology
- Chemomab and Scipher Medicine have announced they will merge (posted on July 13 2026)..
- Apnimed has filed its IPO. Its stock ticker will be APMD. (posted on July 13 2026).
- The new name of EG 427 is Cyllene Therapeutics. (posted on July 10 2026).
Popular contacts in Biotechnology
News
Press releases by Twist Bioscience
- Twist Bioscience | Twist Bioscience to Present at Flash Memory Summit
- Twist Bioscience | Twist Bioscience to Present at Flash Memory Summit
- Twist Bioscience | Twist Bioscience and Biotia Receive Expanded Emergency Use Authorization to Report Genetic Variants of SARS-CoV-2
- Twist Bioscience | Twist Bioscience Highlights White Paper Sizing Future DNA Data Storage Market
- Twist Bioscience | Twist Bioscience Highlights White Paper Sizing Future DNA Data Storage Market
- Twist Bioscience | Twist Bioscience and Biotia Receive Expanded Emergency Use Authorization to Report Genetic Variants of SARS-CoV-2
- Twist Bioscience | Twist Bioscience to Present at UBS Genomics 2.0 and Medtech Innovations Summit
- Twist Bioscience | Twist Bioscience to Present at UBS Genomics 2.0 and Medtech Innovations Summit
- Twist Bioscience | Twist Bioscience to Report Fiscal 2022 Third Quarter Financial Results on Friday, August 5, 2022
- Twist Bioscience | Twist Bioscience to Report Fiscal 2022 Third Quarter Financial Results on Friday, August 5, 2022
- View more press releases Close
Social media about Twist Bioscience
- Twist Bioscience on Wikipedia, Google News & Yahoo Finance
- Twist Bioscience on LinkedIn, X (Twitter) & YouTube
